SHG:603439 - Guizhou Sanli Pharmaceutical Co Ltd

Guizhou Sanli Pharmaceutical C
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2013 Q4	2014 Q4	2015 Q2	2015 Q4	2016 Q4	2017 Q4	2018 Q2	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	725.29M 18.5%	881.03M 21.5%	938.97M 6.6%	968.49M 3.1%	991.77M 2.4%	1.03B 4.3%	1.2B 16.1%	1.39B 15.8%	1.4B 0.8%	1.46B 4.2%	1.63B 11.9%	1.71B 4.5%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	227.21M 13.8%	265.75M 17.0%	277.01M 4.2%	283.84M 2.5%	294.45M 3.7%	305.79M 3.9%	339.5M 11.0%	389.02M 14.6%	383.35M -1.5%	387.93M 1.2%	436.31M 12.5%	468.68M 7.4%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	498.07M 20.8%	615.28M 23.5%	661.96M 7.6%	684.65M 3.4%	697.32M 1.9%	728.94M 4.5%	861.81M 18.2%	1B 16.3%	1.02B 1.6%	1.07B 5.3%	1.2B 11.7%	1.24B 3.4%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	602.59M 15.9%	715.78M 18.8%	775.95M 8.4%	804.28M 3.7%	835.6M 3.9%	878.26M 5.1%	977.32M 11.3%	1.12B 14.9%	1.13B 0.7%	1.17B 3.4%	1.35B 15.7%	1.41B 4.5%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	375.37M 17.2%	450.03M 19.9%	498.94M 10.9%	520.43M 4.3%	541.15M 4.0%	572.47M 5.8%	637.82M 11.4%	734.31M 15.1%	747.82M 1.8%	781.48M 4.5%	916.29M 17.3%	944.25M 3.1%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	122.7M 33.1%	165.25M 34.7%	163.02M -1.3%	164.21M 0.7%	156.17M -4.9%	156.47M 0.2%	224M 43.2%	268.29M 19.8%	271.02M 1.0%	291.28M 7.5%	282.38M -3.1%	295.09M 4.5%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	116.86M -	-	148.6M -	-	138.67M -	-	191.94M -	-	232.68M -	-	294.87M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	116.86M 27.7%	157.23M 34.5%	152.28M -3.1%	152.57M 0.2%	146.89M -3.7%	144M -2.0%	201.28M 39.8%	232.49M 15.5%	238.24M 2.5%	255.61M 7.3%	292.7M 14.5%	293.82M 0.4%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.29 26.1%	0.39 34.5%	0.37 -5.1%	0.37 0%	0.36 -2.7%	0.35 -2.8%	0.49 40.0%	0.56 14.3%	0.58 3.6%	0.63 8.6%	0.71 12.7%	0.72 1.4%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.29 26.1%	0.39 34.5%	0.37 -5.1%	0.37 0%	0.36 -2.7%	0.35 -2.8%	0.49 40.0%	0.56 14.3%	0.58 3.6%	0.63 8.6%	0.71 12.7%	0.72 1.4%